Ministry of Love’s Meg Vitale diagnosed with cancer; future shows on hold
Mon, Aug 13, 2012 (4:47 p.m.)
Ministry of Love announced this week that its singer, Meg Vitale, second from right, has been diagnosed with papillary thyroid carcinoma, and that the band’s CD release party on August 17 will be its last for the foreseeable future.
Photo: Laura Davis
The Details
- Ministry of Love CD release party
- August 17, 5 p.m., $12
- House of Blues at Mandalay Bay, 632-7600
Local band Ministry of Love announced this week that its singer, Meg Vitale, has been diagnosed with cancer, and that its CD release show scheduled for Friday, August 17, at House of Blues may be its last show for the foreseeable future.
An official statement sent out Monday by bassist Patrick “Pulsar” Trout explains, “our singer Meg Vitale … got the results of her medical tests back, and she has been diagnosed with papillary thyroid carcinoma, a type of thyroid cancer.” The cancer has “spread to her lymph nodes, meaning she is going to have to undergo surgery and also radiation treatments to combat this illness.”
Trout says the band is “looking forward to putting on a great show for you all. This may be our last show for some time, so if you were thinking about going, it would be awesome to see you guys there.”
Ministry of Love signed a deal with New York-based Negative Progression Records late last year after nearly four years of touring. Their first EP for Negative Progression was Party Animals. The most recent EP is called A Promise for Forever.

Discussion:
In an effort to increase the dialogue on our stories, we will be requiring Facebook accounts to leave comments on lasvegasweekly.com stories. We believe that Weekly readers are likely to have Facebook accounts already and more apt to comment on this site with that account rather than have to create an account with us. If, however, you do not have a Facebook account, click here to sign up for one. If you have questions, comments or concerns about this new commenting policy, please let us know.
For any other questions related to commenting on Weekly stories, please read our full policy.